| (USD) | Dec 2019 | Y/Y change |
|---|---|---|
| Revenue | 13.33M | — |
| Operating expense | — | — |
| Net income | -17.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IPHA returned -1.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +26.3% |
| 1 year | -1.8% |
| 5 years | -39.3% |
| All-time high | $7.60 (Apr 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IPHA would be worth today ›No. Innate Pharma S.A. has not paid a dividend in the past 12 months.
Innate Pharma S.A. stock trades on NASDAQ under the ticker symbol IPHA.
Innate Pharma S.A. is part of the Healthcare sector.
Innate Pharma S.A. has a market cap of 246.86M USD, based on the latest quote.
Innate Pharma S.A. is scheduled to report earnings on Sep 17, 2026.
